1. Home
  2. OCS vs FFC Comparison

OCS vs FFC Comparison

Compare OCS & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • FFC
  • Stock Information
  • Founded
  • OCS 2003
  • FFC 1983
  • Country
  • OCS Switzerland
  • FFC United States
  • Employees
  • OCS N/A
  • FFC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • FFC Trusts Except Educational Religious and Charitable
  • Sector
  • OCS Health Care
  • FFC Finance
  • Exchange
  • OCS Nasdaq
  • FFC Nasdaq
  • Market Cap
  • OCS 869.8M
  • FFC 785.8M
  • IPO Year
  • OCS N/A
  • FFC N/A
  • Fundamental
  • Price
  • OCS $21.71
  • FFC $16.70
  • Analyst Decision
  • OCS Strong Buy
  • FFC
  • Analyst Count
  • OCS 4
  • FFC 0
  • Target Price
  • OCS $41.00
  • FFC N/A
  • AVG Volume (30 Days)
  • OCS 77.9K
  • FFC 164.1K
  • Earning Date
  • OCS 11-06-2025
  • FFC 01-01-0001
  • Dividend Yield
  • OCS N/A
  • FFC 6.79%
  • EPS Growth
  • OCS N/A
  • FFC N/A
  • EPS
  • OCS N/A
  • FFC N/A
  • Revenue
  • OCS $960,668.00
  • FFC N/A
  • Revenue This Year
  • OCS $36.75
  • FFC N/A
  • Revenue Next Year
  • OCS $1,261.53
  • FFC N/A
  • P/E Ratio
  • OCS N/A
  • FFC N/A
  • Revenue Growth
  • OCS N/A
  • FFC N/A
  • 52 Week Low
  • OCS $14.00
  • FFC $11.90
  • 52 Week High
  • OCS $23.08
  • FFC $14.96
  • Technical
  • Relative Strength Index (RSI)
  • OCS 76.98
  • FFC 50.66
  • Support Level
  • OCS $21.19
  • FFC $16.55
  • Resistance Level
  • OCS $21.79
  • FFC $16.81
  • Average True Range (ATR)
  • OCS 0.66
  • FFC 0.15
  • MACD
  • OCS 0.28
  • FFC -0.03
  • Stochastic Oscillator
  • OCS 93.88
  • FFC 36.47

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

Share on Social Networks: